These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13973797)

  • 1. The pathophysiology of Wilson's disease.
    REILLY RW
    Med Clin North Am; 1963 Jan; 47():207-17. PubMed ID: 13973797
    [No Abstract]   [Full Text] [Related]  

  • 2. [Wilson's disease or hepatolenticular degeneration].
    Mensing B; Nowak A; Zweifel S; Terracciano L; Bernsmeier C; Filipowicz Sinnreich M
    Ther Umsch; 2018 Nov; 75(4):241-248. PubMed ID: 30468117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.
    CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM
    Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058
    [No Abstract]   [Full Text] [Related]  

  • 4. The mechanism of copper deposition in the liver in hepatolenticular degeneration (Wilson's disease).
    UZMAN LL; IBER FL; CHALMERS TC
    Am J Med Sci; 1956 May; 231(5):511-8. PubMed ID: 13313537
    [No Abstract]   [Full Text] [Related]  

  • 5. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
    SCHEINBERG IH
    Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
    [No Abstract]   [Full Text] [Related]  

  • 6. Copper content of hair and nails in Wilson's disease (hepatolenticular degeneration).
    RICE EW; GOLDSTEIN NP
    Metabolism; 1961 Dec; 10():1085-7. PubMed ID: 14491888
    [No Abstract]   [Full Text] [Related]  

  • 7. On the relationship of urinary copper excretion to the aminoaciduria in Wilson's disease (hepatolenticular degeneration).
    UZMAN LL
    Am J Med Sci; 1953 Dec; 226(6):645-52. PubMed ID: 13104417
    [No Abstract]   [Full Text] [Related]  

  • 8. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper removal strategies for Wilson's disease crisis in the ICU.
    Reynolds HV; Talekar CR; Bellapart J; Leggett BA; Boots RJ
    Anaesth Intensive Care; 2014 Mar; 42(2):253-7. PubMed ID: 24580393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occurrence of copper metabolism abnormalities in the families of four individuals with newly diagnosed Wilson's disease].
    Dastych M
    Vnitr Lek; 1997 Feb; 43(2):87-90. PubMed ID: 9245074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and treatment of Wilson's disease.
    Tankanow RM
    Clin Pharm; 1991 Nov; 10(11):839-49. PubMed ID: 1794220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease.
    Iyengar V; Brewer GJ; Dick RD; Chung OY
    J Lab Clin Med; 1988 Mar; 111(3):267-74. PubMed ID: 3125292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
    Sato M; Hayashi A; Ito H; Tojo M; Arima M
    No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper excretion in the urine of normal individuals and of patients with hepatolenticular degeneration (Wilson's disease).
    PORTER H
    Arch Biochem Biophys; 1951 Apr; 31(2):262-5. PubMed ID: 14830233
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of D,L-penicillamine on the urinary excretion of copper and calcium in hepatolenticular degeneration (Wilson's disease).
    LITIN RB; GOLDSTEIN NP; RANDALL RV; POWER MH; DIESSNER GR
    Neurology; 1960 Feb; 10():123-6. PubMed ID: 14417516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.